Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00335556 · OUTCOME

Number of Patients With INI1 Mutations in Renal and Extrarenal Malignant Rhabdoid Tumor by Fluorescent in Situ Hybridization

Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors · Source last updated 2017-07-21

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
Count participants
Interval / dispersion
Not reported
Time frame
At baseline

Analysis population: Eligible patients with reported INI1 mutation data.

Groups in this outcome

UH-1

Cyclophosphamide/carboplatin/etoposide; vincristine/doxorubicin/cyclophosphomide; x 30 weeks; XRT.

Window/UH-1

Window therapy of vincristine/irinotecan;Cyclophosphamide/carboplatin/etoposide; vincristine/doxorubicin/cyclophosphomide; x 30 weeks; XRT.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
UH-126
Window/UH-11

Reported measurements

Source class 1
Values in Count participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
UH-123Not reportedNot reportedNot reportedNot reported
Window/UH-11Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        23
      2. group Id
        OG001
        value
        1
denoms
  1. counts
    1. group Id
      OG000
      value
      26
    2. group Id
      OG001
      value
      1
    units
    Participants
groups
  1. description
    Cyclophosphamide/carboplatin/etoposide; vincristine/doxorubicin/cyclophosphomide; x 30 weeks; XRT.
    id
    OG000
    title
    UH-1
  2. description
    Window therapy of vincristine/irinotecan;Cyclophosphamide/carboplatin/etoposide; vincristine/doxorubicin/cyclophosphomide; x 30 weeks; XRT.
    id
    OG001
    title
    Window/UH-1
param Type
NUMBER
population Description
Eligible patients with reported INI1 mutation data.
reporting Status
POSTED
time Frame
At baseline
title
Number of Patients With INI1 Mutations in Renal and Extrarenal Malignant Rhabdoid Tumor by Fluorescent in Situ Hybridization
type
SECONDARY
unit Of Measure
Count participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice